Clinical Study on Basti and Trikatu Gutika in Diabetic Neuropathy

Single Arm Clinical Study on Mustadi Yapana Basti and Trikatu Gutika in Diabetic Neuropathy W.S.R T. Diabetic Neuropathy Symptom Score and Diabetic Neuropathy Examination Score - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064708

Enrollment

Registered

2024-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing and able to participate in the study Patients with clinical signs and symptoms of Diabetic Neuropathy having HBA1C less than 11 Patient having Diabetic Neuropathy Symptom Gradation Score greater and equal to 3 Diabetic Neuropathy Examination Score greater and equal to 3 Patients who are suitable for Basti Patients who had not participated in any research projects since last 6 months Patients irrespective of sex socio-economical status and religion aged between 30 to 70 years Patients who follows instructions advised by researcher strictly

Exclusion criteria

Exclusion criteria: Patient not willing for trial Patient having severe disease with complication like AIDS Cardiovascular disease Pulmonary disease Tuberculosis malignancy will be rejected Patients having gross disability in performing daily normal routine patients or confined to wheelchair Patients with poorly controlled Hypertension Patients who were participating in any other clinical trials (since last 6 months) Patients contraindicated for Basti mentioned in classics Patient who do not follow instruction suggested by researcher strictly Pregnant females and lactating mothers Acute complications of hyperglycemia like DKA

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Mustadi Yapana Basti and Trikatu Gutika in management of Diabetic Neuropathy on Diabetic Neuropathy Symptoms Score and Diabetic Neuropathy Examination ScoreTimepoint: On 0th day, 6th day, 12th day, 18th day, 24th day, 30th day, 36th day of trial	—

Secondary

Measure	Time frame
1. To evaluate the efficacy of Mustadi Yapana Basti & Trikatu Gutika in management of Diabetic Neuropathy on Semmes-Weinstein Monofilament Examination & S- LANSS Pain Score. 2. To study Ayurvedic & modern literature regarding Diabetic NeuropathyTimepoint: On 0th day, 6th day, 12th day, 18th day, 24th day, 30th day, 36th day	—

Countries

India

Contacts

Public ContactAshish Thatere

Government Ayurvedic College and Hospital Nagpur

ashish.thatere@gmail.com94237406821

Outcome results